Navigation Links
T2™ Tibial Nailing System

ProductsT2™ Tibial Nailing System
Company Stryker Corporation
Item T2™ Tibial Nailing System
Features 
  • Three nails are available: standard, proximal, and distal - providing a long working distance to treat a variety of fractures.
  • Accommodating reamed or unreamed procedures.
  • Providing locking options for all types of fractures, plus the Advanced Locking Mode for increased rotational stability.
  • Static, dynamic and controlled apposition/compression locking options.
  • Description Stryker Orthopedics has now created a new generation locking nail system, bringing together all the capabilities and benefits of separate nailing systems to create a single, integrated surgical resource for fixation of long bone fractures.

    Through the development of a common, streamlined and intuitive surgical approach, both in principle and in detail, the T2&trade Tibial Nailing System offers significantly increased speed and functionality for the treatment of fractures as well as simplifying the training requirements for all personnel involved.
    Info Stryker Corporation
    Customer Service: (269) 385-2600
    Web site: http://www.stryker.com/

    Related medicine products :

    1. T2™ Humeral Nailing System
    2. Ascent Primary Knee System - Ascent/Maxim CoCr I-Beam Tibial Tray
    3. Advance Uni-Comparental Knee Components - Uni All-poly Tibial Component
    4. Advance Uni-Comparental Knee Components - Uni Metal-backed Tibial Component
    5. Advance Uni-Compartmental Knee Components - Uni Metal-backed Tibial Component
    6. BioPro Uni-compartmental Knee System - Uni-compartmental Tibial Tray
    7. Genesis II Tibial Instrumentation
    8. MIS Tibial Stylus
    9. MIS Tibial Saw Guide
    10. Tibial Alignment Guide Assembly
    11. MIS Proximal Tibial Alignment Guide
    Inquire...
    Inquire...
    ... Optimal for Subcellular Fractionation, ... x g (30,000 rpm) with ... from 0.25 up to 85 ... 2° C to 40° C ...
    ... Fractionation, Proteins and Viruses • ... with fixed-angle rotor • Spin ... 85 mL • Operating temperature ... C • Rotors certified by ...
    Medicine Products:
    (Date:8/20/2014)... GA (PRWEB) August 20, 2014 ... to healthcare, Jvion successfully predicted stage iii and ... that, in some situations, approached 90%. A company ... been achieved in commercial or academic settings. The ... prevent all types of hospital-acquired conditions to help ...
    (Date:8/20/2014)... Oshkosh, Wisconsin (PRWEB) August 20, 2014 ... to the general public at fair prices. The well-known ... ability, and she is now touring in 19 cities, ... locations where the television personality will visit are Albany, ... Kalamazoo, Colorado Springs, Albuquerque, Beverly Hills and San Diego. ...
    (Date:8/20/2014)... (PRWEB) August 20, 2014 Blaine ... the innovative RevitaDERM® Psoriasis Treatment to ... associated with psoriasis. This all-in-one product was created ... RevitaDERM® Psoriasis Treatment is powered by coal tar ... associated with this effective ingredient. , RevitaDERM® ...
    (Date:8/20/2014)... August 20, 2014 The “Human ... Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid ... Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast to ... drivers,restraints, challenges, opportunities, current market trends,and strategies impacting ... estimates and forecasts of the revenue and share ...
    (Date:8/20/2014)... 20, 2014 AttorneyOne.com, a recognized authority on ... from the FDA on Sodium Chloride IV . ... lot of Sodium Chloride IV 0.9%, USP 1000 mL, by ... presence of particulate matter. Sodium Chloride Injection, USP is used ... priming solution in hemodialysis procedures. , The reason ...
    Breaking Medicine News(10 mins):Health News:Jvion Achieves Benchmark Accuracy in Pressure Ulcer Prediction 2Health News:Theresa Caputo Tour Tickets for Sale at Ticketability.com Cause a Buying Frenzy Among Customers Over Their Offering of Deeply Discounted Seats 2Health News:RevitaDERM® Psoriasis Treatment Now Available At Over 7,600 CVS/pharmacies 2Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Sodium Chloride IV 0.9% by Baxter Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2
    ... heart attacks, strokes among those without established heart ... An analysis of studies supports a growing belief ... be expanded to include healthy people without established ... 10 trials involving more than 70,000 participants found ...
    ... Services to Focus on the Delivery of Early Stage Services -, ... July 1 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: ... global life sciences markets, today announced that it has completed the ... Under the terms of the agreement, INC Research, a leading global ...
    ... new treatments eliminate risks of traditional procedures , , ROSEMONT, ... respond successfully to initial treatment may have a second chance at ... area, according to a study published in the July 2009 issue ... Academy of Orthopaedic Surgeons (JAAOS). ...
    ... Netherlands: Survivors of childhood cancer run particular risks ... 25th annual conference of the European Society of ... July). Dr. Sharon Lie Fong, of the Department ... Centre, Rotterdam, The Netherlands, said that, although such ...
    ... , AstraZeneca Patent Shown to be Invalid Based on New ... , , NEW YORK, July 1 Article ... validity of AstraZeneca,s Crestor U.S. drug patent, in closing out ... premier validity evidence which can show the Crestor patent to ...
    ... ... Center Leverages Fusionfx Solution Suite to Improve Patient Experience , ... Scottsdale, AZ (Vocus) June ... a nationally recognized non-profit provider of integrated health services, has chosen the Fusionfx ...
    Cached Medicine News:Health News:Study Supports Wider Use of Statins 2Health News:Study Supports Wider Use of Statins 3Health News:MDS Inc. Completes Divestiture of MDS Pharma Services Phase II-IV Operations 2Health News:Emerging Techniques Put a New Twist on Ankle Repair 2Health News:Emerging Techniques Put a New Twist on Ankle Repair 3Health News:Cancer survivors at greater risk of birth complications; special monitoring needed 2Health News:Crestor Patent Invalidity Evidence Uncovered By Article One Partners Community 2Health News:Crestor Patent Invalidity Evidence Uncovered By Article One Partners Community 3Health News:Crestor Patent Invalidity Evidence Uncovered By Article One Partners Community 4Health News:Virginia Mason Signs with Carefx to Implement Fusionfx Solution Suite 2Health News:Virginia Mason Signs with Carefx to Implement Fusionfx Solution Suite 3
    (Date:8/19/2014)... KIRKLAND, Wash. , Aug. 19, 2014 ... solutions, will be exhibiting at the 2014 NPPA Summer ... The company will be showcasing its 340B software products ... leader in 340B splitting solutions, supplying over 400 customers ... a range of 340B solutions including its latest solution, ...
    (Date:8/19/2014)... YORK , Aug. 19, 2014 /PRNewswire-iReach/ -- ChemImage ... will present a scientific poster describing an innovative diagnostic ... SPEC 2014: Shedding New Light on Disease (SPEC) conference ... Dr. Treado,s poster entitled, "Development of in vitro ... Imaging" will be discussed during the conference poster session ...
    (Date:8/19/2014)... , Aug. 19, 2014  Tokyo-based Atonarp Inc. ... funding round led by Walden Riverwood Ventures with ... development of Atonarp,s Smart Spectrometer technology platform, which ... company has targeted the oil & gas and ... "We are excited to partner with Atonarp in ...
    Breaking Medicine Technology:Talyst Exhibits at the NPPA Summer Conference 2ChemImage Scientists Present Latest Developments for in vitro Detection of Colorectal Cancer Using Raman Molecular Imaging (RMI) at International Conference Focused on Biomedical Applications of Raman Spectroscopy 2Atonarp Inc. Raises $8M Series A Round Led by Walden Riverwood Ventures 2